Red Violet is a Boca Raton identity-intelligence vendor that just showed how far a high-fixed-cost data platform can stretch once customer adds accelerate, then immediately sold a large block of new stock. The operating print is the cleanest in the company's public life: licensing demand broadened across investigative, collections, and background screening, while FOREWARN, the safety application built for real-estate professionals, pushed into home healthcare. The investment debate is not whether the machine works. It is whether a cash-rich, debt-light compounder needed to dilute existing holders to fund a second act.
Management added a record cohort of IDI customers in the quarter and pushed adjusted operating profit to a forty two percent margin. Contractual pricing still covers most of the book, and cash conversion stayed honest enough that the midyear cash pile already covered working needs before the August raise. The counterargument is simple and unattractive for a self-funding franchise. A company generating free cash and carrying no bank debt sold nearly two million shares at $60, a roughly twelve percent increase in the share count, and still has no named acquisition to show for it.
The next several quarters resolve whether FOREWARN's healthcare expansion and a defined acquisition framework convert that war chest into identity-graph assets, or whether the capital sits idle while the multiple already prices the leverage story. Gross revenue retention slipped two points, the IDI real-estate vertical remains soft, and a New Jersey Daniel's Law case sits in the legal docket. Does the raise buy a durable second vertical, or did shareholders just fund optionality they already owned?